Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
28.34
-1.52 (-5.09%)
At close: May 30, 2025, 4:00 PM
29.99
+1.65 (5.82%)
After-hours: May 30, 2025, 7:55 PM EDT
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $265.29 million as of May 30, 2025. Its market cap has increased by 547.04% in one year.
Market Cap
265.29M
Enterprise Value
231.07M
1-Year Change
547.04%
Ranking
Category
Stock Price
$28.34
Market Cap Chart
Since January 31, 2014, Tvardi Therapeutics's market cap has decreased from $282.00M to $265.29M, a decrease of -5.93%. That is a compound annual growth rate of -0.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 279.50M | 898.21% |
| Dec 31, 2024 | 28.00M | -30.86% |
| Dec 29, 2023 | 40.50M | -92.98% |
| Dec 30, 2022 | 577.10M | -11.37% |
| Dec 31, 2021 | 651.10M | -13.65% |
| Dec 31, 2020 | 754.00M | 0.27% |
| Dec 31, 2019 | 752.00M | 46.65% |
| Dec 31, 2018 | 512.80M | 28.49% |
| Dec 29, 2017 | 399.10M | 57.44% |
| Dec 30, 2016 | 253.50M | -44.78% |
| Dec 31, 2015 | 459.10M | 102.16% |
| Dec 31, 2014 | 227.10M | -19.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 667.92B |
| Johnson & Johnson | 373.76B |
| AbbVie | 328.97B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.96B |
| Abbott Laboratories | 233.16B |
| AstraZeneca | 224.00B |
| Novartis AG | 219.70B |